Gabriel Tinoco Selected Research

Gabriel Tinoco Research Topics

12	Neoplasms (Cancer) 08/2022 - 01/2011
5	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2015
2	Disease Progression 09/2021 - 01/2021
2	Chondrosarcoma 01/2015 - 01/2015
1	Thrombocytopenia (Thrombopenia) 05/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Polyradiculopathy 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Liposarcoma 01/2021
1	Heart Failure 05/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Cardiac Arrhythmias (Arrythmia) 05/2017
1	Chondroma (Enchondroma) 01/2015
1	Glioma (Gliomas) 01/2015
1	Triple Negative Breast Neoplasms 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011

2	Immune Checkpoint InhibitorsIBA 05/2022 - 05/2020
2	pazopanib FDA Link 01/2021 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2015 - 01/2015
2	EnzymesIBA 01/2015 - 01/2015
1	VimentinIBA 08/2022
1	DesminIBA 08/2022
1	Sunitinib (Sutent)FDA Link 09/2021
1	Phosphotransferases (Kinase)IBA 09/2021
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	larotrectinibIBA 01/2021
1	pembrolizumabIBA 06/2020
1	NivolumabIBA 06/2020
1	LactamsIBA 05/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020
1	Circulating Tumor DNAIBA 11/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	AGI-5198IBA 01/2015
1	alpha-hydroxyglutarateIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Hormones (Hormone)IBA 01/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2013
1	AntigensIBA 01/2011